Unifiram
Experimental nootropic related to Sunifiram: studied only in animals, with no human data.
Pharmacology
Contents
Related comparisons
Sunifiram vs UnifiramDETAILED OVERVIEW
What is Unifiram?
Unifiram (DM-232) is an experimental compound designed in the lab as a relative of Sunifiram, another nootropic (a substance meant to support brain function). It is not approved as a medicine anywhere: in the United Kingdom the Psychoactive Substances Act bans it, and elsewhere it is sold as a research chemical.
In animal studies on rats it improved memory, and it probably acts through the brain's glutamate messenger system, but its exact mechanism is not clear. It has hardly been studied in humans, so there are no reliable data on its real effects or safety. User reports mention anxiety, tension, restlessness and sleep problems. In theory it could raise the risk of seizures in epilepsy. Its safety in pregnancy and breastfeeding is not established because there are no human data, so it should be avoided.
Mechanism
AMPA-PAM (Sunifiram-like)
Half-life
No human data
Legal status
Investigational, not approved
Anecdotal reports describe Unifiram as a promising but still experimental nootropic with a notably varied effect profile. Community accounts report stimulating qualities, with potential to induce anxiety in some users, while others note synergy with caffeine and occasional mild euphoria. A confidence boost and mentally-online energizing effect are commonly mentioned. Mental clarity is reportedly enhanced through AMPA-like modulation, improving verbal fluidity, cognition, and acetylcholine release. Compared to Sunifiram, Unifiram is characterized as less activating and more pro-cognitive. Overall positioned as a solid but experimental ampakine option that produces confidence and mental enhancement in some users while inducing anxiousness or tension in others, with response highly individual.
⚠ Not clinical evidence – based on user accounts.
Receptor profile
- AMPA receptorsStrong
- Hippocampal excitatory transmissionStrong
- Cholinergic systemModerate
Safety
Side effects, stop signs, contraindications
Side effects · 6
- No human safety data, only preclinical (rodent) and anecdotal reports
- Anxiety, tension and restlessness (highly individual response)
- Stimulating, energizing effect that can tip into overstimulation at higher doses
- Possible sleep disruption if taken late in the day (stimulant-like profile)
- Headache or agitation theoretically arising from glutamatergic (AMPA/NMDA) modulation
- Unknown long-term safety, unknown tolerance and risk profile
Contraindications · 5
- Pregnancy and breastfeeding: strictly avoid due to lack of human data
- Caution with anxiety disorders or panic tendency (the stimulating effect may worsen them)
- Epilepsy or seizure-threshold disorders: glutamatergic excitation may theoretically raise seizure risk
- Combined with other stimulants or caffeine, increased agitation and anxiety are possible
- Experimental, nowhere-approved substance; no established safe dosing or drug-interaction profile
Related Nootropics
Same therapeutic category
FAQ
FAQ
Unifiram is an experimental, lab-designed compound developed as a relative of the nootropic Sunifiram, and it showed memory-enhancing effects at very low doses in animal studies. Importantly, there is essentially no human research on it, so this is a purely research-stage substance with very little data on its real-world effects or safety in people.
Telegram
Have a question about Unifiram?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.